Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...
Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...
Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...
Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...
The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...
Unfortunately, too many insurers — including Medicare — still see obesity as a cosmetic issue instead of the disease that it ...
In this morning’s readout from Novo's phase 2 trial of monlunabant in 243 people with obesity and metabolic syndrome, it ...
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback